nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Night blindness—Varenicline—nicotine dependence	0.195	0.204	CcSEcCtD
Carteolol—Rash generalised—Varenicline—nicotine dependence	0.108	0.113	CcSEcCtD
Carteolol—Eye irritation—Varenicline—nicotine dependence	0.0537	0.0562	CcSEcCtD
Carteolol—Lacrimation increased—Varenicline—nicotine dependence	0.0498	0.0521	CcSEcCtD
Carteolol—Photophobia—Varenicline—nicotine dependence	0.0431	0.0451	CcSEcCtD
Carteolol—Diabetes mellitus—Varenicline—nicotine dependence	0.0383	0.0401	CcSEcCtD
Carteolol—Visual disturbance—Varenicline—nicotine dependence	0.0351	0.0368	CcSEcCtD
Carteolol—Hypoglycaemia—Varenicline—nicotine dependence	0.0341	0.0357	CcSEcCtD
Carteolol—Cerebrovascular accident—Varenicline—nicotine dependence	0.034	0.0356	CcSEcCtD
Carteolol—Depression—Varenicline—nicotine dependence	0.0256	0.0268	CcSEcCtD
Carteolol—Conjunctivitis—Varenicline—nicotine dependence	0.0249	0.0261	CcSEcCtD
Carteolol—Sinusitis—Varenicline—nicotine dependence	0.0241	0.0252	CcSEcCtD
Carteolol—Bradycardia—Varenicline—nicotine dependence	0.0235	0.0246	CcSEcCtD
Carteolol—Visual impairment—Varenicline—nicotine dependence	0.0222	0.0232	CcSEcCtD
Carteolol—Arrhythmia—Varenicline—nicotine dependence	0.0206	0.0215	CcSEcCtD
Carteolol—Dysgeusia—Varenicline—nicotine dependence	0.0196	0.0206	CcSEcCtD
Carteolol—Vision blurred—Varenicline—nicotine dependence	0.0189	0.0198	CcSEcCtD
Carteolol—Syncope—Varenicline—nicotine dependence	0.018	0.0188	CcSEcCtD
Carteolol—Palpitations—Varenicline—nicotine dependence	0.0177	0.0186	CcSEcCtD
Carteolol—Loss of consciousness—Varenicline—nicotine dependence	0.0176	0.0185	CcSEcCtD
Carteolol—Oedema—Varenicline—nicotine dependence	0.0164	0.0171	CcSEcCtD
Carteolol—Shock—Varenicline—nicotine dependence	0.0161	0.0169	CcSEcCtD
Carteolol—Hypotension—Varenicline—nicotine dependence	0.0153	0.016	CcSEcCtD
Carteolol—Insomnia—Varenicline—nicotine dependence	0.0148	0.0155	CcSEcCtD
Carteolol—Dyspnoea—Varenicline—nicotine dependence	0.0146	0.0153	CcSEcCtD
Carteolol—Hypersensitivity—Varenicline—nicotine dependence	0.0121	0.0126	CcSEcCtD
Carteolol—Asthenia—Varenicline—nicotine dependence	0.0117	0.0123	CcSEcCtD
Carteolol—Dizziness—Varenicline—nicotine dependence	0.0108	0.0113	CcSEcCtD
Carteolol—Headache—Varenicline—nicotine dependence	0.0103	0.0107	CcSEcCtD
Carteolol—Nausea—Varenicline—nicotine dependence	0.00972	0.0102	CcSEcCtD
Carteolol—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00596	0.134	CbGpPWpGaD
Carteolol—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00465	0.104	CbGpPWpGaD
Carteolol—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0037	0.0829	CbGpPWpGaD
Carteolol—ADRB1—Monoamine GPCRs—DRD2—nicotine dependence	0.00239	0.0536	CbGpPWpGaD
Carteolol—ADRB2—Monoamine GPCRs—DRD2—nicotine dependence	0.00234	0.0524	CbGpPWpGaD
Carteolol—ADRB1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00201	0.0451	CbGpPWpGaD
Carteolol—ADRB2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00197	0.0441	CbGpPWpGaD
Carteolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00153	0.0344	CbGpPWpGaD
Carteolol—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00151	0.034	CbGpPWpGaD
Carteolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00124	0.0279	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000988	0.0221	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000966	0.0217	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000701	0.0157	CbGpPWpGaD
Carteolol—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000661	0.0148	CbGpPWpGaD
Carteolol—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000652	0.0146	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000638	0.0143	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000624	0.014	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000558	0.0125	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000547	0.0123	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000546	0.0122	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000535	0.012	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000507	0.0114	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000496	0.0111	CbGpPWpGaD
Carteolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000461	0.0103	CbGpPWpGaD
Carteolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000451	0.0101	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000438	0.00982	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.000428	0.00961	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000416	0.00933	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.000407	0.00913	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000398	0.00892	CbGpPWpGaD
Carteolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000395	0.00886	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.000389	0.00872	CbGpPWpGaD
Carteolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000387	0.00867	CbGpPWpGaD
Carteolol—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000301	0.00675	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000299	0.00671	CbGpPWpGaD
Carteolol—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.000294	0.0066	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.000293	0.00657	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000235	0.00528	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000235	0.00527	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00023	0.00516	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.00023	0.00515	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000214	0.00479	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	0.000209	0.00469	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000208	0.00465	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	0.000203	0.00455	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	0.00017	0.00381	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	0.000166	0.00373	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	0.000154	0.00346	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	0.000151	0.00339	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—WASF2—nicotine dependence	0.000146	0.00328	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—WASF2—nicotine dependence	0.000143	0.00321	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—WASF1—nicotine dependence	0.00014	0.00314	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—WASF1—nicotine dependence	0.000137	0.00307	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	0.000126	0.00283	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	0.000123	0.00277	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000113	0.00253	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DRD2—nicotine dependence	9.12e-05	0.00205	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DRD2—nicotine dependence	8.93e-05	0.002	CbGpPWpGaD
